3 additional hospitals are slated to begin surgical procedures as well....the replacement heart is for patients with no hope of a transplant and expectations are around 4,000 patients a year to receive the units...BD
Johns Hopkins Hospital is one of four sites selected to begin implanting the AbioCor Implantable Replacement Heart in patients. The heart was developed by
Abiomed Inc.
The U.S. Food and Drug Administration has given Humanitarian Device Exemption approval to the AbioCor, which is intended to replace a severely damaged human heart in patients who are not eligible for a transplant and have no other treatment alternative.
Such patients would otherwise die of heart failure.
Abiomed expects to charge $250,000 per AbioCor unit in a controlled roll out at up to five U.S. centers.
Hopkins Hospital to begin implanting AbioCor replacement hearts - Baltimore Business Journal:
0 comments :
Post a Comment